Privia Health Group Inc (PRVA)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ
Market Cap: $3.14B
Last updated: Nov 17, 2026 at 11:06 AM ET
Privia Health Group Inc (PRVA) Financials: Revenue, Profit and Cash Flow
Privia Health Group reported revenue of $2.12B for the fiscal year ended Dec 31, 2025, up 22.3% from the year before. That year, net income was $29.73M with a net margin of 1.4%, operating cash flow was $163.40M and free cash flow was $162.20M. The quarter ended Sep 30, 2026 had revenue of $656.96M and net income of $14.59M.
Revenue and Margins
The operating margin was 1.6% in the fiscal year ended Dec 2025. Over the 7 years to Dec 2025, revenue grew from $657.61M, a compound annual rate of 18.2%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $2.12B | +22.3% | 88.1% | 1.6% | 1.4% |
| Dec 2024 | $1.74B | +4.7% | 86.9% | 1.0% | 1.0% |
| Dec 2023 | $1.66B | +22.2% | 88.1% | 1.2% | 1.3% |
| Dec 2022 | $1.36B | +40.4% | 87.4% | -1.4% | -0.9% |
| Dec 2021 | $966.22M | +18.3% | 81.9% | -22.5% | -19.7% |
| Dec 2020 | $817.08M | +3.9% | 87.1% | 3.1% | 3.8% |
| Dec 2019 | $786.36M | +19.6% | 87.9% | 2.0% | 1.0% |
| Dec 2018 | $657.61M | N/A | 8.6% | 0.3% | -0.5% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 74.5% from the year before. In the quarter ended Sep 2026, net income rose 48.7% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.12B | $1.74B | $1.66B | $1.36B | $966.22M | $817.08M | $786.36M | $657.61M |
| Cost of revenue | $252.73M | $227.00M | $197.66M | $170.84M | $174.73M | $105.01M | $95.26M | $601.15M |
| Gross profit | $1.87B | $1.51B | $1.46B | $1.19B | $791.49M | $712.07M | $691.10M | $56.46M |
| Operating income | $34.23M | $16.98M | $20.65M | -$19.12M | -$217.44M | $25.38M | $16.06M | $2.15M |
| Net income | $29.73M | $17.04M | $21.03M | -$12.06M | -$190.65M | $30.90M | $7.95M | -$3.04M |
| EBITDA | $53.84M | $35.14M | $35.55M | -$13.32M | -$214.81M | $27.34M | $17.82M | $3.23M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $656.96M | $632.63M | $603.85M | $541.17M | $580.42M | $521.15M | $480.10M | $460.90M | $437.92M | $422.33M | $415.24M | $440.83M |
| Gross profit | $587.29M | $563.27M | $535.43M | $474.32M | $518.98M | $456.24M | $420.57M | $401.13M | $381.85M | $365.22M | $361.19M | $388.42M |
| Operating income | $20.54M | $11.77M | $7.42M | $11.28M | $14.40M | $3.34M | $5.22M | $5.25M | $5.81M | $5.10M | $823.00K | $1.42M |
| Net income | $14.59M | $9.73M | $3.71M | $10.59M | $9.81M | $3.29M | $6.05M | $5.37M | $3.98M | $4.64M | $3.06M | $2.32M |
Balance Sheet
As of Dec 2025, cash and equivalents exceeded short-term debt of $2.20M by $477.49M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $1.37B | $1.14B | $999.90M | $792.81M | $686.37M | $328.97M | $270.20M | $249.49M |
| Current assets | $911.00M | $834.82M | $700.80M | $551.96M | $446.68M | $190.08M | $129.60M | $115.49M |
| Cash and equivalents | $479.69M | $491.15M | $389.51M | $347.99M | $320.58M | $84.63M | $46.89M | $39.11M |
| Total liabilities | $578.43M | $452.34M | $392.51M | $273.76M | $236.19M | $185.32M | $162.75M | $163.44M |
| Short-term debt | $2.20M | $2.55M | $3.04M | $3.01M | $875.00K | $875.00K | $3.38M | $7.13M |
| Long-term debt | N/A | N/A | N/A | N/A | $31.69M | $32.78M | $39.73M | N/A |
| Shareholder equity | $737.22M | $635.18M | $561.44M | $499.09M | $426.87M | $146.75M | $110.21M | $88.50M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $1.56B | $1.49B | $1.42B | $1.37B | $1.35B | $1.27B | $1.18B | $1.14B | $1.15B | $1.08B | $1.03B | $999.90M |
| Total liabilities | $690.80M | $650.51M | $611.99M | $578.43M | $588.23M | $539.00M | $474.01M | $452.34M | $483.38M | $434.01M | $408.76M | $392.51M |
| Cash and equivalents | $446.28M | $412.20M | $419.52M | $479.69M | $441.35M | $390.13M | $469.33M | $491.15M | $422.00M | $387.35M | $351.14M | $389.51M |
| Shareholder equity | $815.72M | $782.33M | $753.06M | $737.22M | $709.12M | $682.86M | $659.44M | $635.18M | $614.89M | $595.41M | $576.80M | $561.44M |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 99.3% of operating cash flow. Dividends came to 0.8% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $163.40M | $109.28M | $80.78M | $47.20M | $55.06M | $38.89M | $24.36M | $5.25M |
| Capital expenditures | $1.20M | $5.02M | $113.00K | $104.00K | $547.00K | $380.00K | $5.71M | $220.00K |
| Free cash flow | $162.20M | $104.26M | $80.67M | $47.09M | $54.51M | $38.51M | $18.65M | $5.03M |
| Dividends paid | $1.34M | $0 | $5.69M | $0 | $0 | N/A | N/A | N/A |
| Share repurchases | N/A | N/A | N/A | N/A | $12.69M | $0 | $0 | N/A |
| Investing cash flow | -$181.57M | -$11.98M | -$42.97M | -$104.00K | -$32.77M | -$380.00K | -$5.71M | -$165.00K |
| Financing cash flow | $6.70M | $4.33M | $3.71M | -$19.68M | $213.66M | -$767.00K | -$10.87M | $15.36M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $28.94M | $1.10M | -$49.47M | $127.50M | $51.99M | $7.97M | -$24.06M | $74.80M | $33.15M | $34.47M | -$33.14M | $64.10M |
| Capital expenditures | N/A | N/A | $26.00K | $1.20M | $1.20M | $0 | $0 | $15.00K | $5.01M | $0 | $5.01M | $23.00K |
| Free cash flow | N/A | N/A | -$49.49M | $126.30M | $50.79M | $7.97M | -$24.06M | $74.78M | $28.15M | $34.47M | -$38.14M | $64.08M |
Frequently Asked Questions About PRVA
What is Privia Health Group's annual revenue?
Privia Health Group reported revenue of $2.12B for the fiscal year ended Dec 31, 2025.
How fast is Privia Health Group's revenue growing?
Revenue was up 22.3% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 16.1%.
Is Privia Health Group profitable?
Yes. Privia Health Group reported net income of $29.73M for the fiscal year ended Dec 31, 2025, with a net margin of 1.4%.
How much free cash flow does PRVA generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $163.40M minus capital expenditures of $1.20M produced free cash flow of $162.20M.
How much debt does Privia Health Group have?
The balance sheet dated Dec 31, 2025 reported short-term debt of $2.20M and cash and equivalents of $479.69M.
PRVA pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors